In a surprising turn of events, a lawyer from the office of New York Attorney General Letitia James is stepping into the spotlight to oppose the progressive push for so-called “gender-affirming care” at a federal workshop.
This event, hosted by the Trump administration’s Federal Trade Commission in Washington on Wednesday, July 9, 2025, brings together a diverse coalition to scrutinize the controversial industry surrounding transgender medical interventions for minors, Daily Wire reported.
The workshop is no small gathering; it’s a potential launching pad for significant federal action against practices the FTC is investigating for being “unfair and deceptive.” Experts, activists, and whistleblowers will openly share their concerns. The administration has made a bold move to confront an issue that has become a cultural lightning rod.
Among the participants is Glenna Goldis, an assistant attorney general under Letitia James, though she’s quick to clarify she’s speaking in her capacity. Her presence is striking given James’s vocal support for transgender procedures, which the AG has defended as essential medical care. Goldis, however, isn’t buying the narrative.
Goldis, who describes herself as a “lefty lesbian lawyer,” has openly criticized the risks of pushing gender ideology on children. She has joined a politically diverse coalition that includes detransitioners like Chloe Cole and Prisha Mosley, medical whistleblowers, and conservative thinkers from groups like the Heritage Foundation. This rare alliance unites members through a shared skepticism of the healthcare industry’s approach.
“You can see in the public record that Letitia James’ view is not my view,” Goldis stated in a recent interview. Well, that’s putting it mildly—James has gone so far as to legally challenge Trump administration policies aimed at protecting kids from surgeries and hormones. Goldis, on the other hand, sees a dangerous taboo that needs shattering.
“There’s a taboo out there which is just performing so much work for the gender doctors,” Goldis argued passionately. She’s not wrong; the healthcare industry has raked in profits while critics often silence opposing views by accusing them of bias or insensitivity. She aims to break that barrier and amplify dissenting voices.
Goldis also points to the historical tactic of transgender advocates linking their cause to gay rights since the 1990s, using the LGBTQ label to gain broader acceptance. “The general public can be forgiven for thinking that there is a connection there,” she noted. But she’s calling foul on the assumption that these issues are inherently aligned.
Observers view the workshop as a fact-finding mission, a typical FTC step before it cracks down on questionable industries. A memo from earlier this year suggests the agency is building on the Trump administration’s efforts to curb what many consider radical gender policies. This event could trigger a much larger federal response.
Goldis isn’t fighting alone; the LGB Courage Coalition has joined her in pushing for evidence-based medical care instead of medicalizing gender nonconformity. They offer a refreshing counterpoint to the well-funded nonprofits and law firms like the ACLU that, according to Goldis, sway gay individuals toward the transgender agenda with awards and job offers. The resource gap is stark, but the underdogs are raising their voices.
“I just think our voice has to be heard,” Goldis insisted, lamenting the lack of a megaphone for those without industry backing. Her point hits hard—without the deep pockets of big healthcare or legal giants, grassroots voices like hers are often drowned out. Yet, here she is, refusing to be silenced.
Letitia James, meanwhile, has dismissed protective policies as “cruel, discriminatory, dangerous,” claiming they ignore science and law. Her stance couldn’t be more at odds with the workshop’s participants, who argue that unrestricted access to these interventions for minors is the real danger. The clash of perspectives is as clear as day.
This coalition stands out because diverse voices—left-leaning individuals like Goldis, conservative experts, and medical professionals—have united to expose industry practices. They’re standing shoulder-to-shoulder against a single issue, a rare sight in today’s polarized climate. Their alliance could shift public perception of these controversial treatments.
As the FTC gathers input from affected citizens, the workshop may lay the groundwork for legal challenges to come. The industry under scrutiny has long operated with little pushback, but if Goldis and her allies have their way, that era might be nearing its end. It’s a fight worth watching, especially for those concerned about the rush to medicalize young lives.
